STAAR Surgical Company (STAA)
USD 15.09
(-6.51%)
USD 15.09
(-6.51%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 35.13 Million USD | 45.4% |
| 2022 | 24.16 Million USD | 39.87% |
| 2021 | 17.27 Million USD | -4.62% |
| 2020 | 18.11 Million USD | 5.65% |
| 2019 | 17.14 Million USD | 2.62% |
| 2018 | 16.7 Million USD | 25.5% |
| 2017 | 13.31 Million USD | -10.22% |
| 2016 | 14.82 Million USD | -6.88% |
| 2015 | 15.92 Million USD | 1.3% |
| 2014 | 15.71 Million USD | 25.6% |
| 2013 | 12.51 Million USD | 7.2% |
| 2012 | 11.67 Million USD | 6.77% |
| 2011 | 10.93 Million USD | 3.7% |
| 2010 | 10.54 Million USD | -28.86% |
| 2009 | 14.82 Million USD | -11.09% |
| 2008 | 16.66 Million USD | 30.82% |
| 2007 | 12.74 Million USD | -1.53% |
| 2006 | 12.93 Million USD | -11.97% |
| 2005 | 14.69 Million USD | -2.55% |
| 2004 | 15.08 Million USD | 17.83% |
| 2003 | 12.8 Million USD | 8.85% |
| 2002 | 11.76 Million USD | -22.78% |
| 2001 | 15.23 Million USD | -26.8% |
| 2000 | 20.8 Million USD | -6.69% |
| 1999 | 22.3 Million USD | 10.95% |
| 1998 | 20.1 Million USD | 36.73% |
| 1997 | 14.7 Million USD | 18.55% |
| 1996 | 12.4 Million USD | 29.17% |
| 1995 | 9.6 Million USD | 11.63% |
| 1994 | 8.6 Million USD | 7.5% |
| 1993 | 8 Million USD | 66.67% |
| 1992 | 4.8 Million USD | 77.78% |
| 1991 | 2.7 Million USD | 22.73% |
| 1990 | 2.2 Million USD | -43.59% |
| 1989 | 3.9 Million USD | -18.75% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 40.36 Million USD | 2.75% |
| 2024 Q2 | 39.28 Million USD | 1.82% |
| 2024 Q1 | 38.58 Million USD | 9.82% |
| 2023 Q4 | 35.13 Million USD | 13.1% |
| 2023 FY | 35.13 Million USD | 45.4% |
| 2023 Q3 | 31.06 Million USD | 21.89% |
| 2023 Q2 | 25.48 Million USD | -8.36% |
| 2023 Q1 | 27.8 Million USD | 15.09% |
| 2022 Q3 | 19.93 Million USD | 10.18% |
| 2022 Q2 | 18.08 Million USD | -1.96% |
| 2022 Q4 | 24.16 Million USD | 21.23% |
| 2022 Q1 | 18.45 Million USD | 6.81% |
| 2022 FY | 24.16 Million USD | 39.87% |
| 2021 Q4 | 17.27 Million USD | 4.58% |
| 2021 FY | 17.27 Million USD | -4.62% |
| 2021 Q1 | 16.78 Million USD | -7.3% |
| 2021 Q2 | 15.59 Million USD | -7.14% |
| 2021 Q3 | 16.51 Million USD | 5.95% |
| 2020 FY | 18.11 Million USD | 5.65% |
| 2020 Q4 | 18.11 Million USD | -0.67% |
| 2020 Q3 | 18.23 Million USD | 2.23% |
| 2020 Q2 | 17.83 Million USD | 1.54% |
| 2020 Q1 | 17.56 Million USD | 2.47% |
| 2019 Q4 | 17.14 Million USD | 4.27% |
| 2019 FY | 17.14 Million USD | 2.62% |
| 2019 Q2 | 16.32 Million USD | -0.68% |
| 2019 Q3 | 16.44 Million USD | 0.69% |
| 2019 Q1 | 16.43 Million USD | -1.59% |
| 2018 Q4 | 16.7 Million USD | 3.24% |
| 2018 Q1 | 13.44 Million USD | 1.01% |
| 2018 FY | 16.7 Million USD | 25.5% |
| 2018 Q2 | 14.38 Million USD | 7.01% |
| 2018 Q3 | 16.18 Million USD | 12.46% |
| 2017 Q1 | 14.64 Million USD | -1.21% |
| 2017 Q2 | 13.45 Million USD | -8.11% |
| 2017 Q3 | 13.27 Million USD | -1.37% |
| 2017 FY | 13.31 Million USD | -10.22% |
| 2017 Q4 | 13.31 Million USD | 0.27% |
| 2016 FY | 14.82 Million USD | -6.88% |
| 2016 Q3 | 15.89 Million USD | 1.29% |
| 2016 Q2 | 15.69 Million USD | -2.04% |
| 2016 Q1 | 16.01 Million USD | 0.62% |
| 2016 Q4 | 14.82 Million USD | -6.73% |
| 2015 Q4 | 15.92 Million USD | 8.88% |
| 2015 FY | 15.92 Million USD | 1.3% |
| 2015 Q1 | 15.27 Million USD | -2.82% |
| 2015 Q2 | 14.15 Million USD | -7.33% |
| 2015 Q3 | 14.62 Million USD | 3.31% |
| 2014 Q2 | 14.93 Million USD | 8.32% |
| 2014 Q1 | 13.78 Million USD | 10.16% |
| 2014 FY | 15.71 Million USD | 25.6% |
| 2014 Q4 | 15.71 Million USD | -0.09% |
| 2014 Q3 | 15.73 Million USD | 5.35% |
| 2013 Q3 | 11.88 Million USD | 6.81% |
| 2013 Q1 | 11.01 Million USD | -5.68% |
| 2013 FY | 12.51 Million USD | 7.2% |
| 2013 Q4 | 12.51 Million USD | 5.34% |
| 2013 Q2 | 11.12 Million USD | 1.03% |
| 2012 Q2 | 11.25 Million USD | 1.01% |
| 2012 Q3 | 11.79 Million USD | 4.75% |
| 2012 Q4 | 11.67 Million USD | -1.02% |
| 2012 FY | 11.67 Million USD | 6.77% |
| 2012 Q1 | 11.14 Million USD | 1.94% |
| 2011 FY | 10.93 Million USD | 3.7% |
| 2011 Q3 | 10.61 Million USD | 7.62% |
| 2011 Q2 | 9.86 Million USD | -1.06% |
| 2011 Q1 | 9.96 Million USD | -5.46% |
| 2011 Q4 | 10.93 Million USD | 3.02% |
| 2010 FY | 10.54 Million USD | -28.86% |
| 2010 Q4 | 10.54 Million USD | -3.73% |
| 2010 Q1 | 11.05 Million USD | -25.4% |
| 2010 Q2 | 10.91 Million USD | -1.26% |
| 2010 Q3 | 10.95 Million USD | 0.33% |
| 2009 Q1 | 16.3 Million USD | -2.2% |
| 2009 Q2 | 15.67 Million USD | -3.86% |
| 2009 FY | 14.82 Million USD | -11.09% |
| 2009 Q4 | 14.82 Million USD | -3.11% |
| 2009 Q3 | 15.29 Million USD | -2.4% |
| 2008 Q2 | 15.57 Million USD | -1.88% |
| 2008 Q1 | 15.87 Million USD | 24.56% |
| 2008 FY | 16.66 Million USD | 30.82% |
| 2008 Q4 | 16.66 Million USD | 5.35% |
| 2008 Q3 | 15.82 Million USD | 1.6% |
| 2007 Q1 | 12.49 Million USD | -3.43% |
| 2007 FY | 12.74 Million USD | -1.53% |
| 2007 Q4 | 12.74 Million USD | -7.6% |
| 2007 Q3 | 13.78 Million USD | 6.53% |
| 2007 Q2 | 12.94 Million USD | 3.59% |
| 2006 FY | 12.93 Million USD | -11.97% |
| 2006 Q3 | 13.83 Million USD | -1.97% |
| 2006 Q4 | 12.93 Million USD | -6.49% |
| 2006 Q2 | 14.11 Million USD | 0.49% |
| 2006 Q1 | 14.04 Million USD | -4.44% |
| 2005 Q3 | 14.27 Million USD | 1.91% |
| 2005 Q1 | 14.45 Million USD | -4.14% |
| 2005 FY | 14.69 Million USD | -2.55% |
| 2005 Q2 | 14.01 Million USD | -3.09% |
| 2005 Q4 | 14.69 Million USD | 2.94% |
| 2004 Q4 | 15.08 Million USD | 7.94% |
| 2004 FY | 15.08 Million USD | 17.83% |
| 2004 Q1 | 12.92 Million USD | 0.95% |
| 2004 Q2 | 13.3 Million USD | 2.94% |
| 2004 Q3 | 13.97 Million USD | 5.04% |
| 2003 FY | 12.8 Million USD | 8.85% |
| 2003 Q4 | 12.8 Million USD | 6.95% |
| 2003 Q3 | 11.97 Million USD | 0.81% |
| 2003 Q2 | 11.87 Million USD | 2.34% |
| 2003 Q1 | 11.6 Million USD | -1.34% |
| 2002 Q3 | 12.76 Million USD | -4.18% |
| 2002 Q2 | 13.32 Million USD | -4.71% |
| 2002 Q1 | 13.98 Million USD | -8.21% |
| 2002 Q4 | 11.76 Million USD | -7.87% |
| 2002 FY | 11.76 Million USD | -22.78% |
| 2001 FY | 15.23 Million USD | -26.8% |
| 2001 Q1 | 22.54 Million USD | 8.33% |
| 2001 Q2 | 17.31 Million USD | -23.17% |
| 2001 Q4 | 15.23 Million USD | -13.18% |
| 2001 Q3 | 17.54 Million USD | 1.29% |
| 2000 Q3 | 19.57 Million USD | 1.51% |
| 2000 FY | 20.8 Million USD | -6.69% |
| 2000 Q1 | 24.14 Million USD | 8.25% |
| 2000 Q4 | 20.8 Million USD | 6.32% |
| 2000 Q2 | 19.27 Million USD | -20.14% |
| 1999 Q3 | 22.1 Million USD | 12.18% |
| 1999 Q2 | 19.7 Million USD | 0.51% |
| 1999 Q1 | 19.6 Million USD | -2.49% |
| 1999 FY | 22.3 Million USD | 10.95% |
| 1999 Q4 | 22.3 Million USD | 0.9% |
| 1998 FY | 20.1 Million USD | 36.73% |
| 1998 Q3 | 20.7 Million USD | 2.48% |
| 1998 Q4 | 20.1 Million USD | -2.9% |
| 1998 Q1 | 18.9 Million USD | 28.57% |
| 1998 Q2 | 20.2 Million USD | 6.88% |
| 1997 FY | 14.7 Million USD | 18.55% |
| 1997 Q1 | 12.9 Million USD | 4.03% |
| 1997 Q2 | 13.4 Million USD | 3.88% |
| 1997 Q3 | 13.8 Million USD | 2.99% |
| 1997 Q4 | 14.7 Million USD | 6.52% |
| 1996 Q3 | 12.5 Million USD | 5.04% |
| 1996 Q1 | 10.8 Million USD | 12.5% |
| 1996 FY | 12.4 Million USD | 29.17% |
| 1996 Q4 | 12.4 Million USD | -0.8% |
| 1996 Q2 | 11.9 Million USD | 10.19% |
| 1995 Q2 | 8.9 Million USD | -1.11% |
| 1995 Q4 | 9.6 Million USD | 4.35% |
| 1995 FY | 9.6 Million USD | 11.63% |
| 1995 Q1 | 9 Million USD | 4.65% |
| 1995 Q3 | 9.2 Million USD | 3.37% |
| 1994 Q3 | 8.5 Million USD | -2.3% |
| 1994 Q1 | 8.4 Million USD | 5.0% |
| 1994 Q2 | 8.7 Million USD | 3.57% |
| 1994 FY | 8.6 Million USD | 7.5% |
| 1994 Q4 | 8.6 Million USD | 1.18% |
| 1993 Q2 | 6.5 Million USD | 0.0% |
| 1993 FY | 8 Million USD | 66.67% |
| 1993 Q4 | 8 Million USD | 12.68% |
| 1993 Q3 | 7.1 Million USD | 9.23% |
| 1992 Q4 | 4.8 Million USD | 0.0% |
| 1992 FY | 4.8 Million USD | 77.78% |
| 1991 Q4 | 2.7 Million USD | 0.0% |
| 1991 Q1 | 2.2 Million USD | 0.0% |
| 1991 FY | 2.7 Million USD | 22.73% |
| 1990 FY | 2.2 Million USD | -43.59% |
| 1990 Q4 | 2.2 Million USD | 0.0% |
| 1989 FY | 3.9 Million USD | -18.75% |
| 1989 Q4 | 3.9 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -96.509% |
| AngioDynamics, Inc. | 60.61 Million USD | 42.045% |
| AtriCure, Inc. | 67.89 Million USD | 48.26% |
| Avinger, Inc. | 5.29 Million USD | -563.08% |
| Azenta, Inc. | 128.19 Million USD | 72.597% |
| BioLife Solutions, Inc. | 43.45 Million USD | 19.16% |
| The Cooper Companies, Inc. | 735.6 Million USD | 95.224% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -595.644% |
| Femasys Inc. | 667.11 Thousand USD | -5165.935% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | -42.135% |
| Hologic, Inc. | 679.8 Million USD | 94.832% |
| ICU Medical, Inc. | 709.36 Million USD | 95.048% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 97.122% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -909.106% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 32.872% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -4000.336% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -4000.336% |
| Masimo Corporation | 545 Million USD | 93.554% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -2072.239% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 88.439% |
| Nephros, Inc. | 2.47 Million USD | -1322.267% |
| NovoCure Limited | 38.15 Million USD | 7.921% |
| NEXGEL, Inc. | 1.31 Million USD | -2563.381% |
| NEXGEL, Inc. | 1.31 Million USD | -2563.381% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -158.842% |
| OraSure Technologies, Inc. | 47.61 Million USD | 26.219% |
| Pro-Dex, Inc. | 15.26 Million USD | -130.074% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -7005.956% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -1124.853% |
| QuidelOrtho Corporation | 577.8 Million USD | 93.92% |
| Repligen Corporation | 202.32 Million USD | 82.637% |
| Sanara MedTech Inc. | 4.71 Million USD | -644.669% |
| Sharps Technology, Inc. | 1.7 Million USD | -1955.426% |
| Utah Medical Products, Inc. | 9.58 Million USD | -266.625% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 94.37% |
| Jin Medical International Ltd. | 5.05 Million USD | -595.212% |